Sol-Gel Technologies Ltd.
SLGL
Price:
$40.7
Market Cap:
$113.38M
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream that has completed Phase III clinical trials for the treatment of papulopustular rosacea; SGT-210, which is in Phase I clinical trial for the treatment of palmoplantar keratoderma; and Erlotinib, Tapinarof, and roflumilast to treat psoriasis and othe...[Read more]
Industry
Biotechnology
IPO Date
2018-02-01
Stock Exchange
NASDAQ
Ticker
SLGL
PE Ratio
[-12.60]
ROE
[-11.80%]
Current Ratio
[7.32]
Dividend Yield
[0%]
Enterprise Value
[104.34M]
Dividend History
The ROE as of December 2025 (TTM) for Sol-Gel Technologies Ltd. (SLGL) is -11.80%
According to Sol-Gel Technologies Ltd.’s latest financial reports and current stock price. The company's current ROE is -11.80%. This represents a change of 65.20% compared to the average of -7.14% of the last 4 quarters.
Sol-Gel Technologies Ltd. (SLGL) Historical ROE (quarterly & annually)
How has SLGL ROE performed in the past?
The mean historical ROE of Sol-Gel Technologies Ltd. over the last ten years is -8.16%. The current -11.80% ROE has changed 44.66% with respect to the historical average. Over the past ten years (40 quarters), SLGL's ROE was at its highest in in the March 2016 quarter at 36.95%. The ROE was at its lowest in in the March 2023 quarter at -70.65%.
Average
-8.16%
Median
-36.01%
Minimum
-70.48%
Maximum
83.87%
Sol-Gel Technologies Ltd. (SLGL) ROE by Quarter and Year
Discovering the peaks and valleys of Sol-Gel Technologies Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 99.38%
Maximum Annual ROE = 83.87%
Minimum Annual Increase = -710.16%
Minimum Annual ROE = -70.48%
| Year | ROE | Change |
|---|---|---|
| 2024 | -36.67% | -47.97% |
| 2023 | -70.48% | 99.38% |
| 2022 | -35.35% | -710.16% |
| 2021 | 5.79% | -110.06% |
| 2020 | -57.60% | 22.80% |
| 2019 | -46.91% | -6.91% |
| 2018 | -50.39% | -184.12% |
| 2017 | 59.90% | -9.63% |
| 2016 | 66.28% | -20.97% |
| 2015 | 83.87% | -48.33% |
Sol-Gel Technologies Ltd. (SLGL) Average ROE
How has SLGL ROE performed in the past?
The current ROE of Sol-Gel Technologies Ltd. (SLGL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-47.50%
5-year avg
-38.86%
10-year avg
-8.16%
Sol-Gel Technologies Ltd. (SLGL) ROE vs. Peers
How is SLGL’s ROE compared to its peers?
Sol-Gel Technologies Ltd.’s ROE is less than OKYO Pharma Limited (73.68%), less than Clene Inc. (448.29%), greater than Coya Therapeutics, Inc. (-86.00%), greater than Tiziana Life Sciences Ltd (-125.84%), greater than Pliant Therapeutics, Inc. (-71.51%), greater than MacroGenics, Inc. (-98.30%), greater than Zentalis Pharmaceuticals, Inc. (-51.62%), greater than Anebulo Pharmaceuticals, Inc. (-67.78%), greater than Ovid Therapeutics Inc. (-63.74%), greater than Oramed Pharmaceuticals Inc. (-16.16%),
| Company | ROE | Market cap |
|---|---|---|
| 73.68% | $75.60M | |
| 448.29% | $58.52M | |
| -86.00% | $99.69M | |
| -125.84% | $98.64M | |
| -71.51% | $80.50M | |
| -98.30% | $87.30M | |
| -51.62% | $101.15M | |
| -67.78% | $97.37M | |
| -63.74% | $115.21M | |
| -16.16% | $113.33M |
Build a custom stock screener for Sol-Gel Technologies Ltd. (SLGL) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sol-Gel Technologies Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Sol-Gel Technologies Ltd. (SLGL) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Sol-Gel Technologies Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Sol-Gel Technologies Ltd.'s ROE?
How is the ROE calculated for Sol-Gel Technologies Ltd. (SLGL)?
What is the highest ROE for Sol-Gel Technologies Ltd. (SLGL)?
What is the 3-year average ROE for Sol-Gel Technologies Ltd. (SLGL)?
What is the 5-year average ROE for Sol-Gel Technologies Ltd. (SLGL)?
How does the current ROE for Sol-Gel Technologies Ltd. (SLGL) compare to its historical average?